Toumaz said that its decision to reorganise into two distinct businesses was in order to strengthen its focus on both the healthcare and semiconductor divisions: Toumaz UK will focus on health technology & solutions while Toumaz Microsystems will cover integrated circuits for low power wireless communication. Both companies will be subsidiaries of Toumaz Ltd.
Toumaz Microsystems will focus on the design, development and sale of semiconductor chips and solutions for the growing and emerging embedded wireless connectivity market addressing the opportunities in a wide range of internet connected devices. These include home and enterprise automation, healthcare, smart power, security/monitoring systems, intelligent toys and other connectivity-centric cloud-enabled systems. Toumaz Microsystems will become Toumaz’s vehicle for all its wireless chip development and supply.
Toumaz will own 75% of Toumaz Microsystems and has moved its silicon integrated-circuit (IC) design team and related assets to the subsidiary. Imagination will invest a combination of cash, certain licences to Imagination’s hardware and software technologies, and supportive engineering resources, totalling £5m, in Toumaz Microsystems and will own 25% of the business.
Toumaz’s chip businesses and the Group’s ultra-low power radio IP, and licenses of further IP, will be transferred to Toumaz Microsystems. The wireless semiconductor expertise of Toumaz coupled with the hardware and software IP from Imagination will enable Toumaz Microsystems to offer a comprehensive connectivity solution for low-power internet-connected applications.
The subsidiary will focus on developing a new multi-standard connectivity chip, an ultra-low power radio receiver and transmitter chip incorporating the new IEEE standard 802.15.6 (see notes to editors) and other relevant standards. It will be one of the first chips to be based on this new standard and will specifically target Body Area Networks and a range of low-power domestic consumer wireless sensor applications.
Commenting Professor Chris Toumazou, CEO of Toumaz, who will now also become the Chairman of Toumaz Microsystems said: “Establishing Toumaz Microsystems is the next logical step for us, building a subsidiary for our radio IC chip development with investment and support from a strategic partner, Imagination. The rest of the Group, operating now as Toumaz Health Technologies, can then be focused on the applications for our technology in the healthcare and leisure arena. This brings clarity to the business and ensures our all-important silicon devices have a strong roadmap, are delivered in a more structured manner, and have the outlet and backing needed, both for our own healthcare business and also to exploit the huge global opportunities of connected devices.”